Search results
The two sides of AstraZeneca’s vaccine ‘miracle’
Daily Telegraph· 5 days agoAstraZeneca had been unable to identify the cause of the clots and the Government bought its Covid vaccines for the next year’s rollout from rivals. In...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 4 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 3 days agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 7 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may now be “contagious, ...
Biodexa gains license for polyposis asset as stock more than doubles
Pharmaceutical Technology via Yahoo Finance· 6 days agoIn the trial, thirty patients with FAP who are undergoing endoscopic surveillance will be given...
Cardiff Oncology Inc (CRDF) (Q1 2024) Earnings Call Transcript Highlights: Strategic Insights ...
GuruFocus.com via Yahoo Finance· 3 days agoThe company is leveraging Pfizer Ignite's resources to ensure effective trial execution. Q: Could you read some of the scenario planning that you...Q3/Q4 will include about ...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 7 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress
Investing.com· 3 days agoCardiff Oncology, a biopharmaceutical company focused on developing new treatments for cancer, has...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 4 days ago“Everything is riskier now because omicron is so much more contagious,” said Dr. S. Wesley Long, who...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 3 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...